It has been proposed that brain disorders such as AIDS dementia complex, Alzheimers dementia, Parkinsons disease, and possibly schizophrenia are caused by progressive neurodegeneration. Oxidative stress and neuronal damage may occur when the endogenous antioxidative defense systems are severely weakened by aging, imbalanced dietary intake, and environmental or man-made neurotoxins. The objective of our research unit is to prevent brain atrophy and to improve life quality by developing neuroprotective agents and strategies against oxidative brain damage caused by free radicals. We employed both cell cultures and animal models for investigating neuroprotective and neurorescue effects of agents including antioxidants. In vitro results suggest that free radicals are unavoidable by-products of chemical reactions of oxygen, iron, and dopamine. Based on this in vitro finding we have developed a free radical-induced parkinsonian animal model for testing neuroprotective agents. In addition to manganese compounds, we discovered that iron-induced mild to moderate brain injury can be completely prevented by antioxidants such as S-nitrosoglutathione (GSNO) because it inhibits free radical generation and brain lipid peroxidation. GSNO is approximately 100 fold more potent than the endogenous antioxidant glutathione. Preliminary results also showed that GSNO protected brain neurons against damage caused by hemoglobin (i.e., stroke) and proteases (i.e., dementia). The present results indicate that free radicals and oxidative stress play a significant role in causing progressively degenerative brain disorders. The proposed neuroprotective and neurorescue effects of antioxidants can be demonstrated in cell cultures and animal models. The beneficial effects of antioxidants in degenerative brain disorders may be more visible if they were administered to patients in early preclinical stage. - neuroprotection, free radical, antioxidant, hemoglobin, iron, manganese, Parkinson's disease, dementia, oxidant stress, S- nitrosoglutathione

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Intramural Research (Z01)
Project #
1Z01MH002648-07
Application #
6290556
Study Section
Special Emphasis Panel (LCS)
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
1999
Total Cost
Indirect Cost
Name
U.S. National Institute of Mental Health
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Chiueh, Chuang C; Andoh, Tsugunobu; Chock, P Boon (2005) Roles of thioredoxin in nitric oxide-dependent preconditioning-induced tolerance against MPTP neurotoxin. Toxicol Appl Pharmacol 207:96-102
Wang, Xuting; Tomso, Daniel J; Liu, Xuemei et al. (2005) Single nucleotide polymorphism in transcriptional regulatory regions and expression of environmentally responsive genes. Toxicol Appl Pharmacol 207:84-90
Chiueh, Chuang C; Andoh, Tsugunobu; Chock, P Boon (2005) Induction of thioredoxin and mitochondrial survival proteins mediates preconditioning-induced cardioprotection and neuroprotection. Ann N Y Acad Sci 1042:403-18
Andoh, Tsugunobu; Chock, P Boon; Murphy, Dennis L et al. (2005) Role of the redox protein thioredoxin in cytoprotective mechanism evoked by (-)-deprenyl. Mol Pharmacol 68:1408-14
Chiueh, Chuang; Lee, Sang; Andoh, Tsugunobu et al. (2003) Induction of antioxidative and antiapoptotic thioredoxin supports neuroprotective hypothesis of estrogen. Endocrine 21:27-31
Andoh, Tsugunobu; Chiueh, Chuang Chin; Chock, P Boon (2003) Cyclic GMP-dependent protein kinase regulates the expression of thioredoxin and thioredoxin peroxidase-1 during hormesis in response to oxidative stress-induced apoptosis. J Biol Chem 278:885-90
Vaananen, Antiii J; Moed, Mikaela; Tuominen, Raimo K et al. (2003) Angeli's salt induces neurotoxicity in dopaminergic neurons in vivo and in vitro. Free Radic Res 37:381-9
Andoh, Tsugunobu; Chock, P Boon; Chiueh, Chuang C (2002) Preconditioning-mediated neuroprotection: role of nitric oxide, cGMP, and new protein expression. Ann N Y Acad Sci 962:1-7
Chiueh, C C (2001) Iron overload, oxidative stress, and axonal dystrophy in brain disorders. Pediatr Neurol 25:138-47
Andoh, T; Lee, S Y; Chiueh, C C (2000) Preconditioning regulation of bcl-2 and p66shc by human NOS1 enhances tolerance to oxidative stress. FASEB J 14:2144-6

Showing the most recent 10 out of 17 publications